ICE Chemo

From Wikipedia, the free encyclopedia

ICE is a combination chemotherapy regimen employing three drugs: ifosfamide (trade name: Ifex), carboplatin (trade name: Paraplatin®), and etoposide (trade names: VP-16, VePesid®). This regimen is commonly used to treat primary progressive and poor-risk recurrent lymphomas.[1].

In the last few years, it has become more common to include the drug rituximab alongside the ICE protocol. Rituximab is an immunotherapy drug that binds to and helps destroy B cells.[2].

[edit] References

  1. ^ "Follow-up Care & Relapse." Lymphoma Research Foundation. http://www.lymphoma.org/site/pp.aspx?c=chKOI6PEImE&b=1574015&printmode=1
  2. ^ "Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma." ClinicalTrials.gov. http://clinicaltrials.gov/show/NCT00166439